- Staat
- TX
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 24.06.2021
- Impfdatum
- 23.06.2021
- Beginn
- 23.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Extremity contracture
Fall
Fatigue
Feeling cold
Flushing
Gaze palsy
Inappropriate schedule of product administration
Loss of consciousness
Muscular weakness
Musculoskeletal stiffness
Pallor
Respiratory arrest
Seizure like phenomena
Somnolence
Syncope
Vision blurred
Symptomtext
6/23/21 @ 0830 14 y/0 F came to clinic for TDAP, IPV, MMRV, Hep A, and Hep B vaccinations. Pt has NKDA and no PSH/PMH. 6/18/21 pt had her 2nd Pfizer vaccine, no side effects verbalized. Approximately 2 minutes after administration pt was standing against padded pediatric exam table and fell back onto table, her legs buckled and she gently slid down onto floor in sitting position with head slumped down causing her eye glasses to fall off. Pt did not hit head. Syncopal episode lasted 5 seconds. When pt regained consciousness she was alert and oriented, pale and c/o of dizziness and blurred vision. The patients mother and I assisted her to a chair. After 1-2 minutes pt?s eyes rolled back, her left arm contracted up, her entire body stiffened and she was having seizure like activity lasting 5-10 seconds. Pt was flushed and did not breathe during this episode. 911 was called at this time. When patient regained consciousness she c/o of fatigue, feeling cold, dizziness and blurred vision. She was AAOx3 and very pale. After applying her eye glasses her vision improved some, still c/o dizziness and stated she just wanted to go to sleep. Pt was provided a cool rag and was kept awake and talking until EMS arrived. Report given to EMS. F/U call made to pt?s mother whom reported pt was discharged from ER. No lab work or radiology was performed. MD stated that ?this was a normal anxiety related reaction for a patient her age.? Since discharge from hospital pt has been asymptomatic and back to her baseline.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory arrest
- Hospital-Tage
- -
- Labordaten
- Pt was provided a cool rag and was kept awake and talking until EMS arrived. Report given to EMS. F/U call made to pt?s mother whom reported pt was discharged from ER. No lab work or radiology was performed. MD stated that ?this was a normal anxiety related reaction for a patient her age.? Since discharge from hospital pt has been asymptomatic and back to her baseline.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- None.
- Andere Medikamente
- None.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 23.03.2021
- Impfdatum
- 17.03.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood glucose normal
Cardio-respiratory arrest
Death
Loss of consciousness
Resuscitation
Symptomtext
Loss of consciousness, cardiopulmonary arrest aprox. 6 to 7 hours after vaccine administration Could not be resuscitated and ultimately expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- Glucose 184
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Carrots
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 29.03.2021
- Impfdatum
- 18.03.2021
- Beginn
- 26.03.2021
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Generalised tonic-clonic seizure
Pyrexia
Symptomtext
Pentacel was 4th dose of DTaP and IPV and the 3rd dose of Hib. Previous doses had been through Pediarix and the Merck Hib. On the night of 3/25, she had felt warm and fatigued. Around midnight she was sleeping on her father's chest when she began to have a single generalized, tonic-clonic seizure of unknown duration. The family called EMS and she was taken to the ED, where she had a 102.9 fever. She was given ibuprofen, which helped her feel better. Physical exam was normal with no focal findings and they were discharged to follow-up with a PCP. No lab tests were done in the ED.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Generalised tonic-clonic seizure
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Atopic dermatitis
- Andere Medikamente
- None
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 1,6
- Geschlecht
- F
- Eingang
- 24.03.2021
- Impfdatum
- 18.03.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Body temperature increased
Chills
Sleep disorder
Tremor
Symptomtext
She awoke around midnight with shivering/shaking and "clenching" of muscles for about 17 minutes in duration. EMS was on scene when the episodes finally stopped. Pt. was then very sleepy afterwards. Her temperature on arrival of EMS was 99.7, and during transport increased to as high as 104.6. ED visit was unremarkable, she returned to her usual baseline and was discharged to follow up here today. She has been doing tylenol suppositories every 4hr. Pt. had received vaccines earlier in the day on 3/18/21 at her 18mo WCC. She was delayed on vaccines, so received 2nd Hep A, DTaP-IPV/HIB, and varicella No prior history of seizures or febrile seizures No known sick contacts, no daycare
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Food Protein Induced Enterocolitis Syndrome (FPIES)
- Andere Medikamente
- unknown
- Allergien
- oats, rice, soy, wheat
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 16.08.2021
- Impfdatum
- 10.08.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Decreased appetite
Lethargy
Pyrexia
Rash
Symptomtext
Lethargy, decreased appetite, low grade fever off and on, and fine rash that started on hands and feet and then spread up extremities. Mom was giving Tylenol for the low grade fever and giving Pedialyte to prevent any kind of dehydration. She also started giving Benadryl on Saturday per primary provider instruction. Called mom on 8/16/21 to follow up and was told that the child is pretty much back to his normal self.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 13.05.2021
- Impfdatum
- 12.05.2021
- Beginn
- 13.05.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site discolouration
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Lower extremity swelling and purple discoloration with warmth (per mom). Happened about 24 hrs after injections. Legs seemed painful and patient was very fussy. Symptoms started at 6am and I saw baby at 10:30am. Legs were only very mildly swollen with no real erythema or discoloration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discolouration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 05.05.2021
- Impfdatum
- 03.05.2021
- Beginn
- 03.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Hyperaesthesia
Injection site erythema
Injection site pruritus
Injection site swelling
Injection site warmth
Pyrexia
Symptomtext
2 days after vaccine administration right arm swollen, red, hot to the touch. Has been feeling generally fatigued, slight fever. Arm started swelling right away after shots, slowly worsening, worse in the evening, may be getting worse still 2 days later. Very sensitive to touch, itching "like crazy". Left arm slightly swollen but much less so. Treating at home with ice, acetaminophen, and diphenhydramine which do help temporarily.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- unknown, reports arm swelling with previous vaccinations
- Staat
- CA
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 27.04.2021
- Impfdatum
- 12.04.2021
- Beginn
- 22.04.2021
- Tage bis Beginn
- 10,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain
Crying
Haematochezia
Ultrasound abdomen
Symptomtext
4/22 fussy tactile temp, increasing abdominal pain, bloody stool 4/24 ultrasound = intussception
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- 4/24 abd ultrasound
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,1
- Geschlecht
- M
- Eingang
- 25.04.2021
- Impfdatum
- 20.04.2021
- Beginn
- 20.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pallor
Pyrexia
Rash
Rash erythematous
Symptomtext
Patient had erythematous blanching patches erupt on chest, abdomen, back, arms a few minutes after vaccines. No wheezing, no emesis, no diarrhea, no lip swelling. No evidence of anaphylaxis. Was given 12.5mg diphenhydramine and monitored in clinic. Patient improved, thus discharged home. Next day, has a phone visit with physician to follow up, patient continued to do well, did have one fever, the next day, thus given Tylenol, resoled with Tylenol. Called mother again 4/25/21, patient continues to do well without symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Allergy to milk.
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 05.04.2021
- Impfdatum
- 01.04.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site urticaria
Symptomtext
Pt developed erythema and dime size hive to R arm below injection site of MMR. No distress noted. Pt did not show signs of discomfort or itchiness. Primary PCP assessed patient. Observed for additional 15 mins; hive size reduced. Mild erythema still present.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Murmur documented in patient's chart
- Andere Medikamente
- None that we are aware
- Allergien
- Mother denied allergies
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 24.03.2021
- Impfdatum
- 10.03.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dysphagia
Infantile spitting up
Irritability
Neck pain
Otitis media
Pharyngitis
Symptomtext
Seen one week after vaccines at community clinic for irritability and poor swallowing and spitting up of citrus foods. No fever, no diarrhea, no rash. No other symptoms. On exam he was a bit tender on the neck and had pharyngitis and otitis media. He was treated with antibiotics. Symptoms improved within a few days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Neck pain
- Hospital-Tage
- -
- Labordaten
- no tests
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Poor Head Growth
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 22.03.2021
- Impfdatum
- 16.03.2021
- Beginn
- 18.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Hives reported ~48 hours after administration of immunization - unclear if related
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 02.03.2021
- Impfdatum
- 02.03.2021
- Beginn
- 02.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
About a minute after the vaccinations were given her whole body broke out in a urticarial rash.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 22.01.2021
- Impfdatum
- 29.12.2020
- Beginn
- 29.12.2020
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Irritability
Urticaria
Vomiting
Symptomtext
Within 1 hour of immunization, patient developed vomiting and diffuse urticaria with fussiness. She was taken to the Emergency Department and IM epinephrine and IM diphenhydramine were administered approximately 1 hour after symptom onset. All symptoms resolved within 30 minutes. Patient observed for several hours without return of symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None yet
- Aktuelle Erkrankungen
- intermittent peripheral cyanosis
- Vorgeschichte
- eczema
- Andere Medikamente
- triamcinolone acetonide 0.1% ointment, cetirizine, fluticasone propionate 0.05% lotion, cholecalciferol
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 10.09.2022
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Inappropriate schedule of product administration
Symptomtext
First dose on 15Mar2021, 2nd dose on 14Jul2022; Expired Havrix administered; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 2-year-old female patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Havrix (received 1st dose on 15th March 2021). On 14th July 2022, the patient received the 2nd dose of Havrix and Havrix Pre-Filled Syringe Device. On 14th July 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long and expired vaccine used. On an unknown date, the outcome of the drug dose administration interval too long and expired vaccine used were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-AUG-2022 Reporter's comment: The nurse reported that a second dose of Havrix was given to the patient and it was already expired. The Vaccine Administration Facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: The patient received the second dose of Havrix later than the recommended interval which was already expired, which led to lengthening of vaccination schedule and expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 07.07.2022
- Impfdatum
- 29.06.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was expired at time given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 3,0
- Geschlecht
- M
- Eingang
- 03.05.2022
- Impfdatum
- 31.03.2021
- Beginn
- 31.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Eye swelling
Oedema peripheral
Pharyngeal swelling
Swelling face
Swelling of eyelid
Symptomtext
AFTER VACCINES, PT AND MOTHER LEFT TO GO TO STORE. MOM CALLED AND REPORTED THAT PT HAD SUDDEN SWELLING OF BOTH EYES AND THROAT CLEARING APPROX. 20 MINS AFTER VACCINES ADMINISTERED. PARENT WAS ADVISED TO RETURN TO CLINIC. UPON EXAMINATION, PT WAS FOUND TO HAVE MODERATE EDEMA BIL. UPPER AND LOWER EYELIDS AND MILD FACIAL SWELLING. NO RESPIRATORY SYMPTOMS OR RASHES NOTED. BENADRYL AND PREDNISOLONE ADMINISTERED IMMEDIATLEY UPON PT'S RETURN AND PT OBSERVED IN OFFICE X 45 MINS. PT WAS SIGNIFICANTLY IMPROVED PRIOR TO D/C HOME. MOM WAS INSTRUCTED TO CONTINUE BENADRYL AND PRED. X 3 DAYS RTC
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye swelling
- Hospital-Tage
- -
- Labordaten
- ALLERGY PANEL FOR FOOD AND RESPIRATORY ORDERED, MOM NEVER COMPLETED LAB WORK.
- Aktuelle Erkrankungen
- COUGH DX ON 3/12/21 AND WAS INST TO TAKE OTC MUCINEX PRN
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKA, NKDA
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 03.01.2022
- Impfdatum
- 27.12.2021
- Beginn
- 27.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
We administered the Varicella vaccine separately not realizing the MMR vaccine was combined with Varicella therefore administering 2 doses of Varicella on same date of service. Patient had no reaction, mother was advised of error and monitored for the next 2 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 19.07.2021
- Impfdatum
- 13.07.2021
- Beginn
- 13.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Underdose
Symptomtext
a patient was given a dose of Pediatric Havrix/to an adult patient/Mistake was confirmed on 14Jul2021; a patient was given a dose of Pediatric Havrix/to an adult patient; This case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 56-year-old female patient who received HAV (Havrix pediatric) (batch number 5575N, expiry date 19th June 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis and HBV (Engerix B pediatric) (batch number 5295P, expiry date 27th December 2022) for prophylaxis. On 13th July 2021, the patient received Havrix pediatric, Havrix Pre-Filled Syringe Device and the 1st dose of Engerix B pediatric. On 13th July 2021, unknown after receiving Havrix pediatric, Havrix Pre-Filled Syringe Device and Engerix B pediatric, the patient experienced accidental underdose and adult use of a child product. On an unknown date, the outcome of the accidental underdose and adult use of a child product were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: It was reported that an adult patient was given a dose of Pediatric Havrix and a dose of Engerix-B, which led to accidental underdose and adult use of a child product. On 14th July 2021, the mistake was confirmed. The reporter consented to follow up via email. This case had been linked with the case US2020210333, reported by the same reporter. Note: Engerix B pediatric was conservatively captured as a suspect with events accidental underdose and adult use of a child product as it was not mentioned in narrative but was mentioned in structural field of the source document. The clarification has been raised for the same.; Sender's Comments: US-GLAXOSMITHKLINE-US2020210333:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- -
- Geschlecht
- M
- Eingang
- 17.07.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
nonviable after a temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a child male patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2022) for prophylaxis. On an unknown date, the patient received Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional case details were reported as follows: The age at vaccination was not reported. The patient was given a dose of Havrix that was deemed nonviable after a temperature excursion, which led to incorrect storage of drug. No symptoms reported. The reporter consented to follow up. This case was 1st of 9 reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021142812:same reporter US-GLAXOSMITHKLINE-US2021142813:same reporter US-GLAXOSMITHKLINE-US2021142815:same reporter US-GLAXOSMITHKLINE-US2021142816:same reporter US-GLAXOSMITHKLINE-US2021142817:same reporter US-GLAXOSMITHKLINE-US2021142818:same reporter US-GLAXOSMITHKLINE-US2021AMR151443:same reporter US-GLAXOSMITHKLINE-US2021AMR151445:same reporter US-GLAXOSMITHKLINE-US2021AMR151444:same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 23.06.2021
- Impfdatum
- 23.06.2021
- Beginn
- 23.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Wrong product administered
Symptomtext
Administered two doses of Hep A when I mistakenly thought I had given pt a dose of Hep B
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to Incorrect storage of drug The reporter consented to follow up. This is 1 of 11 cases reported by same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to Incorrect storage of drug The reporter consented to follow up. This is 1 of 11 cases reported by same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The case was reported by a medical assistant. The age at vaccination was not reported. The reporter stated that the patient received Havrix that was exposed to a freezing excursion, which led to incorrect storage of drug. The reporter consented to follow up. This is 1 of the 11 link cases, reported by same reporter. Note: As per sales datasheet the expiry date of batch number 5575N is 19th June 2022, however the expiry date was retained as reported 19th June 2020.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to incorrect storage of drug. The reporter consented to follow up. This case is 1 of 11 cases reported by same reporter. The expiry date of vaccine was updated as 19th June 2022 as per sales data sheet and clarification has been raised for the same.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to incorrect storage of drug. The reporter consented to follow up. This is 1 of 11 cases reported by same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to incorrect storage of drug. The reporter consented to follow up. This is 1 of 11 cases reported by same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to incorrect storage of drug. The reporter consented to follow up. This is 1 of 11 cases reported by same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to incorrect storage of drug. The reporter consented to follow up. This is 1 of 11 cases reported by same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to Incorrect storage of drug The reporter consented to follow up. This is 1 of 11 cases reported by same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to Incorrect storage of drug The reporter consented to follow up. This is 1 of 11 cases reported by same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
received Havrix that had been exposed to a freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2020) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. A medical assistant reported that the patient received Havrix that had been exposed to a freezing excursion, which led to Incorrect storage of drug The reporter consented to follow up. This is 1 of 11 cases reported by same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- -
- Geschlecht
- M
- Eingang
- 04.05.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Incorrect dose administered
Symptomtext
inadvertently administered an extra dose of Havrix to a patient; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a adolescent male patient who received HAV (Havrix) (batch number 5575N, expiry date 19th June 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter was physician assistant. The age at vaccination was not reported. The reporter inadvertently administered an extra dose of Havrix to the patient. No details about previous doses were provided. The reporter consented to follow up through Email.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 1,6
- Geschlecht
- M
- Eingang
- 28.04.2021
- Impfdatum
- 27.04.2021
- Beginn
- 27.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Accidental exposure to product
Wrong product administered
Symptomtext
Second varicella was inadvertently given instead of Prevnar.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental exposure to product
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 27.04.2021
- Beginn
- 27.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Epistaxis
Symptomtext
Upon third vaccine administration, epistaxis occurred of unknown cause. Pressure applied on tip of nose for approx. 5-6 minutes to stop bleeding. Bleeding stopped. No adverse reaction noted at the injection sites.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Epistaxis
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- No.
- Vorgeschichte
- No.
- Andere Medikamente
- No.
- Allergien
- NKDA.
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 24.03.2021
- Impfdatum
- 01.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
FLU SHOT GIVEN 4TH TIME AS CHILD HAS DUPLICATE GRITS ACCOUNT - ONLY 1 ACCOUNT WAS BEING UPDATED. FLU #1 - 10/01/2020 FLU#2 - 11/02/2020 FLU#3 - 12/02/2020 FLU#4 - 03/01/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 1,1
- Geschlecht
- M
- Eingang
- 17.03.2021
- Impfdatum
- 11.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Patient was inadvertently administer MMRV
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- None
- Andere Medikamente
- -
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 15.03.2021
- Impfdatum
- 15.03.2021
- Beginn
- 15.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
no adverse events, just given too early
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 15.03.2021
- Impfdatum
- 26.02.2021
- Beginn
- 07.03.2021
- Tage bis Beginn
- 9,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cellulitis
Symptomtext
CELLULITIS RIGHT LEG, GIVEN KEFLEX
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- VIRAL EXANTHAM 16 DAYS EARLIER
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -